Please enable JavaScript to continue using this application.

Compare $HUMA vs $UNCY | Chartloom

Compare

$HUMA vs $UNCY

Humacyte Inc · Unicycive Therapeutics Inc

HUMA

Humacyte Inc

UNCY

Unicycive Therapeutics Inc

Compare $HUMA vs $UNCY

Comparing Humacyte Inc and Unicycive Therapeutics Inc

HUMAHumacyte Inc

UNCYUnicycive Therapeutics Inc

HUMAHumacyte Inc

Market cap

$109M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

14.62x

Rev growth (TTM)

159.3%

YTD performance

-58.4%

52W performance

-76.0%

FCF yield

-89.3%

UNCYUnicycive Therapeutics Inc

Market cap

$110M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.31x

Rev growth (TTM)

—

YTD performance

-29.1%

52W performance

-13.8%

FCF yield

-25.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

HUMA

UNCY

Detailed metrics comparison

HUMA

Humacyte Inc

UNCY

Unicycive Therapeutics Inc

Market Cap

HUMA$109M

UNCY$110M

Enterprise Value

HUMA$96M

UNCY$66M

Price

HUMA$0.41

UNCY$4.11

P/E Ratio

HUMAN/A

UNCYN/A

P/S Ratio

HUMA51.53x

UNCY31.15x

EV/Sales

HUMA45.06x

UNCY0.00x

EV/EBITDA

HUMA0.00x

UNCY0.00x

P/B Ratio

HUMA4.63x

UNCY2.21x

P/FCF Ratio

HUMAN/A

UNCYN/A

EV/FCF

HUMA-0.98x

UNCY-2.35x

PEG Ratio

HUMAN/A

UNCYN/A

Forward P/E (NTM)

HUMAN/A

UNCYN/A

Forward P/S (NTM)

HUMA14.62x

UNCY0.31x

Revenue (TTM)

HUMA$2M

UNCY$0

Revenue Growth (YoY)

HUMA159.3%

UNCYN/A

Forward Rev Growth

HUMA520.3%

UNCY37378.0%

Gross Margin (TTM)

HUMA-494.6%

UNCY0.0%

Operating Margin (TTM)

HUMA0.0%

UNCY0.0%

EBITDA Margin (TTM)

HUMA-4900.0%

UNCY0.0%

Net Margin (TTM)

HUMA-4560.8%

UNCY0.0%

FCF Margin (TTM)

HUMA-4599.7%

UNCYN/A

Net Income (TTM)

HUMA$-97M

UNCY$-35M

FCF (TTM)

HUMA$-98M

UNCY$-28M

EPS (TTM)

HUMA-$0.41

UNCY-$1.31

ROE (TTM)

HUMA-51675.0%

UNCY-8881.0%

ROA (TTM)

HUMA-8476.0%

UNCY-5966.0%

ROIC (TTM)

HUMA-9784.0%

UNCY-8881.0%

Cash

HUMA$80M

UNCY$44M

Debt

HUMA$66M

UNCY$0

Net Cash/Debt

HUMA$14M

UNCY$44M

Current Ratio (TTM)

HUMA6.21x

UNCY3.81x

Quick Ratio (TTM)

HUMA5.38x

UNCY3.28x

Debt/Equity (TTM)

HUMA2.12x

UNCY0.00x

Debt/Assets (TTM)

HUMA0.0%

UNCY0.0%

Interest Coverage (TTM)

HUMAN/A

UNCYN/A

Net Debt/EBITDA (TTM)

HUMA0.00x

UNCY0.00x

Beta

HUMA2.76

UNCY1.78

52W Performance

HUMA-76.0%

UNCY-13.8%

YTD Performance

HUMA-58.4%

UNCY-29.1%

% from 52W High

HUMA-78.6%

UNCY-53.0%

% from 52W Low

HUMA3.7%

UNCY4.6%

Asset Turnover (TTM)

HUMA0.02x

UNCY0.05x

FCF Yield (TTM)

HUMA-89.3%

UNCY-25.4%

Earnings Yield (TTM)

HUMA-88.5%

UNCY-32.1%

Dividend Yield (TTM)

HUMAN/A

UNCYN/A

Rule of 40

HUMA-4,440.4

UNCY0.0

EV/GP/RG

HUMAN/A

UNCYN/A

Ticker research

View HUMA research View UNCY research

Metric	HUMA Humacyte Inc	UNCY Unicycive Therapeutics Inc
Market & Valuation
Market Cap	$109M	$110M
Enterprise Value	$96M	$66M
Price	$0.41	$4.11
P/E Ratio	N/A	N/A
P/S Ratio	51.53x	31.15x
EV/Sales	45.06x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.63x	2.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.98x	-2.35x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	14.62x	0.31x
Revenue & Growth
Revenue (TTM)	$2M	$0
Revenue Growth (YoY)	159.3%	N/A
Forward Rev Growth	520.3%	37378.0%
Profitability
Gross Margin (TTM)	-494.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-4900.0%	0.0%
Net Margin (TTM)	-4560.8%	0.0%
FCF Margin (TTM)	-4599.7%	N/A
Net Income (TTM)	$-97M	$-35M
FCF (TTM)	$-98M	$-28M
EPS (TTM)	-$0.41	-$1.31
ROE (TTM)	-51675.0%	-8881.0%
ROA (TTM)	-8476.0%	-5966.0%
ROIC (TTM)	-9784.0%	-8881.0%
Financial Health
Cash	$80M	$44M
Debt	$66M	$0
Net Cash/Debt	$14M	$44M
Current Ratio (TTM)	6.21x	3.81x
Quick Ratio (TTM)	5.38x	3.28x
Debt/Equity (TTM)	2.12x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.76	1.78
52W Performance	-76.0%	-13.8%
YTD Performance	-58.4%	-29.1%
% from 52W High	-78.6%	-53.0%
% from 52W Low	3.7%	4.6%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.05x
FCF Yield (TTM)	-89.3%	-25.4%
Earnings Yield (TTM)	-88.5%	-32.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-4,440.4	0.0
EV/GP/RG	N/A	N/A
Ticker research	View HUMA research	View UNCY research

Valuation

P/S Ratio

UNCY

31.15x

HUMA

51.53x

EV/FCF

UNCY

-2.35x

HUMA

-0.98x

Growth & revenue

Revenue Growth TTM

HUMA

159.3%

Forward Revenue Growth

UNCY

37378.0%

HUMA

520.3%

Profitability & performance

Gross Margin

UNCY

0.0%

HUMA

-494.6%

ROE

UNCY

-8881.0%

HUMA

-51675.0%

FCF Yield %

UNCY

-25.4%

HUMA

-89.3%

52-Week Performance

UNCY

-13.8%

HUMA

-76.0%

Detailed metrics comparison

HUMA

Humacyte Inc

UNCY

Unicycive Therapeutics Inc

Market Cap

HUMA$109M

UNCY$110M

Enterprise Value

HUMA$96M

UNCY$66M

Price

HUMA$0.41

UNCY$4.11

P/E Ratio

HUMAN/A

UNCYN/A

P/S Ratio

HUMA51.53x

UNCY31.15x

EV/Sales

HUMA45.06x

UNCY0.00x

EV/EBITDA

HUMA0.00x

UNCY0.00x

P/B Ratio

HUMA4.63x

UNCY2.21x

P/FCF Ratio

HUMAN/A

UNCYN/A

EV/FCF

HUMA-0.98x

UNCY-2.35x

PEG Ratio

HUMAN/A

UNCYN/A

Forward P/E (NTM)

HUMAN/A

UNCYN/A

Forward P/S (NTM)

HUMA14.62x

UNCY0.31x

Revenue (TTM)

HUMA$2M

UNCY$0

Revenue Growth (YoY)

HUMA159.3%

UNCYN/A

Forward Rev Growth

HUMA520.3%

UNCY37378.0%

Gross Margin (TTM)

HUMA-494.6%

UNCY0.0%

Operating Margin (TTM)

HUMA0.0%

UNCY0.0%

EBITDA Margin (TTM)

HUMA-4900.0%

UNCY0.0%

Net Margin (TTM)

HUMA-4560.8%

UNCY0.0%

FCF Margin (TTM)

HUMA-4599.7%

UNCYN/A

Net Income (TTM)

HUMA$-97M

UNCY$-35M

FCF (TTM)

HUMA$-98M

UNCY$-28M

EPS (TTM)

HUMA-$0.41

UNCY-$1.31

ROE (TTM)

HUMA-51675.0%

UNCY-8881.0%

ROA (TTM)

HUMA-8476.0%

UNCY-5966.0%

ROIC (TTM)

HUMA-9784.0%

UNCY-8881.0%

Cash

HUMA$80M

UNCY$44M

Debt

HUMA$66M

UNCY$0

Net Cash/Debt

HUMA$14M

UNCY$44M

Current Ratio (TTM)

HUMA6.21x

UNCY3.81x

Quick Ratio (TTM)

HUMA5.38x

UNCY3.28x

Debt/Equity (TTM)

HUMA2.12x

UNCY0.00x

Debt/Assets (TTM)

HUMA0.0%

UNCY0.0%

Interest Coverage (TTM)

HUMAN/A

UNCYN/A

Net Debt/EBITDA (TTM)

HUMA0.00x

UNCY0.00x

Beta

HUMA2.76

UNCY1.78

52W Performance

HUMA-76.0%

UNCY-13.8%

YTD Performance

HUMA-58.4%

UNCY-29.1%

% from 52W High

HUMA-78.6%

UNCY-53.0%

% from 52W Low

HUMA3.7%

UNCY4.6%

Asset Turnover (TTM)

HUMA0.02x

UNCY0.05x

FCF Yield (TTM)

HUMA-89.3%

UNCY-25.4%

Earnings Yield (TTM)

HUMA-88.5%

UNCY-32.1%

Dividend Yield (TTM)

HUMAN/A

UNCYN/A

Rule of 40

HUMA-4,440.4

UNCY0.0

EV/GP/RG

HUMAN/A

UNCYN/A

Ticker research

View HUMA research View UNCY research

Metric	HUMA Humacyte Inc	UNCY Unicycive Therapeutics Inc
Market & Valuation
Market Cap	$109M	$110M
Enterprise Value	$96M	$66M
Price	$0.41	$4.11
P/E Ratio	N/A	N/A
P/S Ratio	51.53x	31.15x
EV/Sales	45.06x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.63x	2.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.98x	-2.35x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	14.62x	0.31x
Revenue & Growth
Revenue (TTM)	$2M	$0
Revenue Growth (YoY)	159.3%	N/A
Forward Rev Growth	520.3%	37378.0%
Profitability
Gross Margin (TTM)	-494.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-4900.0%	0.0%
Net Margin (TTM)	-4560.8%	0.0%
FCF Margin (TTM)	-4599.7%	N/A
Net Income (TTM)	$-97M	$-35M
FCF (TTM)	$-98M	$-28M
EPS (TTM)	-$0.41	-$1.31
ROE (TTM)	-51675.0%	-8881.0%
ROA (TTM)	-8476.0%	-5966.0%
ROIC (TTM)	-9784.0%	-8881.0%
Financial Health
Cash	$80M	$44M
Debt	$66M	$0
Net Cash/Debt	$14M	$44M
Current Ratio (TTM)	6.21x	3.81x
Quick Ratio (TTM)	5.38x	3.28x
Debt/Equity (TTM)	2.12x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.76	1.78
52W Performance	-76.0%	-13.8%
YTD Performance	-58.4%	-29.1%
% from 52W High	-78.6%	-53.0%
% from 52W Low	3.7%	4.6%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.05x
FCF Yield (TTM)	-89.3%	-25.4%
Earnings Yield (TTM)	-88.5%	-32.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-4,440.4	0.0
EV/GP/RG	N/A	N/A
Ticker research	View HUMA research	View UNCY research